“Crash rates over time among younger and older drivers in the SHRP 2 naturalistic driving study.”, J Safety Res, vol. 73, pp. 245-251, 2020.
, “Cytomegalovirus Genetic Diversity Following Primary Infection.”, J Infect Dis, vol. 221, no. 5, pp. 715-720, 2020.
, “Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.”, Addict Sci Clin Pract, vol. 15, no. 1, p. 4, 2020.
, “Dismantling the Fragility Index: A demonstration of statistical reasoning.”, Stat Med, vol. 39, no. 26, pp. 3720-3731, 2020.
, “Do Cultural and Psychosocial Factors Contribute to Type 2 Diabetes Risk? A Look Into Vancouver's South Asian Community.”, Can J Diabetes, vol. 44, no. 1, pp. 14-21, 2020.
, “Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.”, J Subst Abuse Treat, vol. 112S, pp. 41-48, 2020.
, “Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure.”, Vaccines (Basel), vol. 8, no. 3, 2020.
, “Early predictors of developing problematic spasticity following traumatic spinal cord injury: A prospective cohort study.”, J Spinal Cord Med, vol. 43, no. 3, pp. 315-330, 2020.
, “Effect of Concomitant Antibiotic and Vaccine Administration on Serologic Responses to Rotavirus Vaccine.”, J Pediatric Infect Dis Soc, vol. 9, no. 4, pp. 479-482, 2020.
, “Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment: A Randomized Clinical Trial.”, JAMA, vol. 323, no. 1, pp. 35-48, 2020.
, “Endpoints for randomized controlled clinical trials for COVID-19 treatments.”, Clin Trials, vol. 17, no. 5, pp. 472-482, 2020.
, “An evaluation of cytokine and cellular immune responses to heterologous prime-boost vaccination with influenza A/H7N7-A/H7N9 inactivated vaccine.”, Hum Vaccin Immunother, vol. 16, no. 12, pp. 3138-3145, 2020.
, “Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in Thailand.”, Virology, vol. 548, pp. 152-159, 2020.
, “Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy.”, Neurology, vol. 94, no. 14, pp. e1502-e1511, 2020.
, “Flagellin adjuvanted F1/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signatures.”, NPJ Vaccines, vol. 5, no. 1, p. 6, 2020.
, “Genetic factors and risk of type 2 diabetes among women with a history of gestational diabetes: findings from two independent populations.”, BMJ Open Diabetes Res Care, vol. 8, no. 1, 2020.
, “Group sequential tests for treatment effect on survival and cumulative incidence at a fixed time point.”, Lifetime Data Anal, vol. 26, no. 3, pp. 603-623, 2020.
, “Impact of electronic nicotine delivery systems and other respondent characteristics on tobacco use transitions among a U.S. national sample of women of reproductive age.”, Drug Alcohol Depend, vol. 207, p. 107801, 2020.
, “Impact of Personal Protective Equipment on Pediatric Cardiopulmonary Resuscitation Performance: A Controlled Trial.”, Pediatr Emerg Care, vol. 36, no. 6, pp. 267-273, 2020.
, “Impact of Personal Protective Equipment on the Performance of Emergency Pediatric Tasks.”, Pediatr Emerg Care, 2020.
, “Impact of Personal Protective Equipment on the Performance of Emergency Pediatric Procedures by Prehospital Providers.”, Disaster Med Public Health Prep, pp. 1-8, 2020.
, “Intrauterine growth discordance across gestation and birthweight discordance in dichorionic twins.”, Am J Obstet Gynecol, vol. 222, no. 2, pp. 174.e1-174.e10, 2020.
, “Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.”, Ophthalmology, 2020.
, “Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.”, Contemp Clin Trials, vol. 93, p. 106014, 2020.
, “Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.”, AIDS, vol. 34, no. 9, pp. 1289-1301, 2020.
,